Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
BGB324
Description:
BGB324, also called bemcentinib, is a small-molecule inhibitor of the AXL receptor tyrosine kinase studied in cancer treatment.
Related topics:
Sarcoma Diagnosis and Treatment (14%),
Glioma Diagnosis and Treatment (13%),
Lung Cancer Treatments and Mutations (10%),
Chronic Myeloid Leukemia Treatments (8%)
Wikidata ID:
wiki/Q27236818
OpenAlex ID:
keywords/bgb324
Small-Molecule Inhibition of Axl Targets Tumor Immune Suppression and Enhances Chemotherapy in Pancreatic Cancer
2018
·
Kathleen F. Ludwig
, Wenting Du
, et al.
·
Cancer Research
·
168
Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation
2015
·
Cristina Bárcena
, Milica Stefanovic
, et al.
·
Journal of Hepatology
·
164
PDF
Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma
2018
·
Hirokazu Sadahiro
, Kyung-Don Kang
, et al.
·
Cancer Research
·
157
Targeting of TAM Receptors Ameliorates Fibrotic Mechanisms in Idiopathic Pulmonary Fibrosis
2018
·
Milena S. Espindola
, David M. Habiel
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
110
Combined Therapy of AXL and HDAC Inhibition Reverses Mesenchymal Transition in Diffuse Intrinsic Pontine Glioma
2020
·
Michaël H. Meel
, Mark C. de Gooijer
, et al.
·
Clinical Cancer Research
·
73
Phase 1 trial of bemcentinib (BGB324), a first-in-class, selective AXL inhibitor, with docetaxel in patients with previously treated advanced non-small cell lung cancer
2023
·
Sheena Bhalla
, Farjana J. Fattah
, et al.
·
Lung Cancer
·
57
PDF
The role of AXL and the in vitro activity of the receptor tyrosine kinase inhibitor BGB324 in Ewing sarcoma
2014
·
Emmy D.G. Fleuren
, Melissa H.S. Hillebrandt-Roeffen
, et al.
·
Oncotarget
·
56
PDF
AXL inhibition improves BRAF-targeted treatment in melanoma
2022
·
Marta Nyakas
, Karianne Giller Fleten
, et al.
·
Scientific Reports
·
54
PDF
Therapeutic Inhibition of the Receptor Tyrosine Kinase AXL Improves Sensitivity to Platinum and Taxane in Ovarian Cancer
2019
·
Jeanne M. Quinn
, Molly M. Greenwade
, et al.
·
Molecular Cancer Therapeutics
·
54
Small molecule inhibition of Axl receptor tyrosine kinase potently suppresses multiple malignant properties of glioma cells
2015
·
Mikaella Vouri
, Qian An
, et al.
·
Oncotarget
·
54
PDF
Inhibiting the GAS6/AXL axis suppresses tumor progression by blocking the interaction between cancer-associated fibroblasts and cancer cells in gastric carcinoma
2020
·
Cheong A. Bae
, In-Hye Ham
, et al.
·
Gastric Cancer
·
52
PDF
Axl signaling is an important mediator of tumor angiogenesis
2019
·
Mai Tanaka
, Dietmar W. Siemann
·
Oncotarget
·
51
PDF
Axl inhibitor R428 induces apoptosis of cancer cells by blocking lysosomal acidification and recycling independent of Axl inhibition.
2018
·
Fangfang Chen
, Qiaoling Song
, et al.
·
Europe PMC (PubMed Central)
·
50
Soluble AXL as a marker of disease progression and survival in melanoma
2020
·
Karine Flem-Karlsen
, Marta Nyakas
, et al.
·
PLoS ONE
·
47
PDF
Implication of the Receptor Tyrosine Kinase AXL in Head and Neck Cancer Progression
2016
·
Anne Von Mässenhausen
, Johannes Brägelmann
, et al.
·
International Journal of Molecular Sciences
·
47
PDF
Antiviral Screening of Multiple Compounds against Ebola Virus
2016
·
Stuart Dowall
, Kevin Bewley
, et al.
·
Viruses
·
47
PDF
Axl Blockade by BGB324 Inhibits BCR-ABL Tyrosine Kinase Inhibitor–Sensitive and -Resistant Chronic Myeloid Leukemia
2017
·
Isabel Ben-Batalla
, Robert Erdmann
, et al.
·
Clinical Cancer Research
·
46
PDF
Decitabine-Vorinostat combination treatment in acute myeloid leukemia activates pathways with potential for novel triple therapy
2017
·
Christine S. Young
, Kathryn M. Clarke
, et al.
·
Oncotarget
·
45
PDF
Cisplatin and Pemetrexed Activate AXL and AXL Inhibitor BGB324 Enhances Mesothelioma Cell Death from Chemotherapy
2018
·
Derek B. Oien
, Tamás Garay
, et al.
·
Frontiers in Pharmacology
·
40
PDF
Inhibition of the Receptor Tyrosine Kinase AXL Restores Paclitaxel Chemosensitivity in Uterine Serous Cancer
2017
·
Marguerite L. Palisoul
, Jeanne M. Quinn
, et al.
·
Molecular Cancer Therapeutics
·
34
Axl inhibition: a potential road to a novel acute myeloid leukemia therapy?
2015
·
Melanie Janning
, Isabel Ben-Batalla
, et al.
·
Expert Review of Hematology
·
28
PDF
Galectin-3 Stimulates Tyro3 Receptor Tyrosine Kinase and Erk Signalling, Cell Survival and Migration in Human Cancer Cells
2020
·
Nour Al Kafri
, Sassan Hafizi
·
Biomolecules
·
24
PDF
Cabozantinib (XL184) and R428 (BGB324) Inhibit the Growth of Esophageal Squamous Cell Carcinoma (ESCC)
2019
·
Pei-Wen Yang
, Yu-Cheng Liu
, et al.
·
Frontiers in Oncology
·
24
PDF
Inhibition of the Axl pathway impairs breast and prostate cancer metastasis to the bones and bone remodeling
2021
·
Mai Tanaka
, Samantha S. Dykes
, et al.
·
Clinical & Experimental Metastasis
·
23
PDF
Recent discovery and development of AXL inhibitors as antitumor agents
2024
·
Zihang Liu
, Li Chen
, et al.
·
European Journal of Medicinal Chemistry
·
22
Show more works
View as search
Works count:
146
Citation count:
1,865
Year
Topic
Type